Derivative Instruments, Hedging Activities and Fair Value (Tables)
|
9 Months Ended |
Sep. 30, 2017 |
Derivative Instruments, Hedging Activities And Fair Value Disclosure [Abstract] |
|
Schedule of fair value of outstanding derivative contracts |
The fair value of outstanding derivative contracts recorded as assets and liabilities on the Condensed Consolidated Balance Sheets was as follows: | | | | | | | | | | | | | | | | Asset Derivatives | | Liability Derivatives | (In thousands) | | Balance Sheet Location | | Fair Value | | Balance Sheet Location | | Fair Value | September 30, 2017 | | | | | | | | | Derivatives designated as hedging instruments: | Foreign currency exchange forward contracts | | Other current assets | | $ | 2,673 |
| | Other current liabilities | | $ | 92 |
| Cross-currency interest rate swaps | | Other current assets | | 110 |
| |
| | — |
| Interest rate swaps | |
| | — |
| | Other current liabilities | | 197 |
| Interest rate swaps | | Other assets | | 92 |
| | Other liabilities | | 2,773 |
| Total derivatives designated as hedging instruments | | | | $ | 2,875 |
| | | | $ | 3,062 |
| Derivatives not designated as hedging instruments: | Foreign currency exchange forward contracts | | Other current assets | | $ | 572 |
| | Other current liabilities | | $ | 22,698 |
|
| | | | | | | | | | | | | | | | Asset Derivatives | | Liability Derivatives | (In thousands) | | Balance Sheet Location | | Fair Value | | Balance Sheet Location | | Fair Value | December 31, 2016 | | | | | | | | | Derivatives designated as hedging instruments: | Foreign currency exchange forward contracts | | Other current assets | | $ | 473 |
| | Other current liabilities | | $ | 166 |
| Cross-currency interest rate swaps | | Other current assets | | 514 |
| |
| | — |
| Total derivatives designated as hedging instruments | | | | $ | 987 |
| | | | $ | 166 |
| Derivatives not designated as hedging instruments: | Foreign currency exchange forward contracts | | Other current assets | | $ | 4,459 |
| | Other current liabilities | | $ | 3,372 |
|
|
Schedule of effect of derivative instruments |
The effect of derivative instruments on the Condensed Consolidated Statements of Operations and the Condensed Consolidated Statements of Comprehensive Income (Loss), was as follows: Derivatives Designated as Hedging Instruments | | | | | | | | | | | | | | | | | | | (In thousands) | | Amount Recognized in Other Comprehensive Income (“OCI”) on Derivative - Effective Portion | | Location of Amount Reclassified from Accumulated OCI into Income - Effective Portion | | Amount Reclassified from Accumulated OCI into Income - Effective Portion | | Location of Amount Recognized in Income on Derivative - Ineffective Portion and Amount Excluded from Effectiveness Testing | | Amount Recognized in Income on Derivative - Ineffective Portion and Amount Excluded from Effectiveness Testing | | Three Months Ended September 30, 2017: | Foreign currency exchange forward contracts | | $ | 2,333 |
| |
| | $ | — |
| | | | $ | — |
| | Interest rate swaps | | (335 | ) | | | | — |
| | | | — |
| | Cross-currency interest rate swaps | | (72 | ) | | Interest expense | | 252 |
| | Cost of services and products sold | | (103 | ) | (a) | | | $ | 1,926 |
| | | | $ | 252 |
| | | | $ | (103 | ) | | Three Months Ended September 30, 2016: | Foreign currency exchange forward contracts | | $ | 2,378 |
| |
| | $ | — |
| |
| | $ | — |
| | Cross-currency interest rate swaps | | (210 | ) | | Interest expense | | 254 |
| | Cost of services and products sold | | (232 | ) | (a) | | | $ | 2,168 |
| | | | $ | 254 |
| | | | $ | (232 | ) | |
| | | | | | | | | | | | | | | | | | | (In thousands) | | Amount Recognized in OCI on Derivative - Effective Portion | | Location Amount Reclassified from Accumulated OCI into Income - Effective Portion | | Amount Reclassified from Accumulated OCI into Income - Effective Portion | | Location of Amount Recognized in Income on Derivative - Ineffective Portion and Amount Excluded from Effectiveness Testing | | Amount Recognized in Income on Derivative - Ineffective Portion and Amount Excluded from Effectiveness Testing | | Nine Months Ended September 30, 2017: | Foreign currency forward exchange contracts | | $ | 3,096 |
| | Product revenues / Cost of services and products sold | | $ | (185 | ) | | | | $ | — |
| | Interest rate swaps | | (2,878 | ) | | | | — |
| | | | — |
| | Cross currency interest rate swaps | | (195 | ) | | Interest expense | | 745 |
| | Cost of services and products sold | | (420 | ) | (a) | | | $ | 23 |
| | | | $ | 560 |
| | | | $ | (420 | ) | | Nine Months Ended September 30, 2016: | Foreign currency forward exchange contracts | | $ | 1,748 |
| | Product revenues / Cost of services and products sold | | $ | (409 | ) | |
| | $ | — |
| | Cross currency interest rate swaps | | (2,361 | ) | | Interest expense | | 478 |
| | Cost of services and products sold | | 3,987 |
| (a) | | | $ | (613 | ) | | | | $ | 69 |
| | | | $ | 3,987 |
| |
(a) These gains (losses) offset foreign currency fluctuation effects on the debt principal.
Derivatives Not Designated as Hedging Instruments | | | | | | | | | | | | | | Location of Gain (Loss) Recognized in Income on Derivative | | Amount of Gain (Loss) Recognized in Income on Derivative for the Three Months Ended September 30 (b) | (In thousands) | | | 2017 | | 2016 | Foreign currency exchange forward contracts | | Cost of services and products sold | | $ | (7,025 | ) | | $ | 552 |
|
| | | | | | | | | | | | | | Location of Gain (Loss) Recognized in Income on Derivative | | Amount of Gain (Loss) Recognized in Income on Derivative for the Nine Months Ended September 30 (b) | (In thousands) | | | 2017 | | 2016 | Foreign currency forward exchange contracts | | Cost of services and products sold | | $ | (18,764 | ) | | $ | 2,292 |
|
(b) These gains (losses) offset amounts recognized in cost of services and products sold principally as a result of intercompany or third party foreign currency exposures.
|
Summary of notional amount of foreign currency exchange contracts and cross-currency interest rate swaps |
The following table indicates the notional amounts of the Company's interest rate swaps at September 30, 2017: | | | | | | | | | | | | Annual Notional Amount | | Interest Rates | (In millions) | | | Receive | | Pay | Maturing 2018 through 2021 | | $ | 300.0 |
| | Floating U.S. dollar rate | | Fixed U.S. dollar rate |
Cross-Currency Interest Rate Swaps (CCIRs) The Company uses CCIRs in conjunction with certain debt issuances in order to secure a fixed local currency interest rate. Under these CCIRs, the Company receives interest based on a fixed or floating U.S. dollar rate and pays interest on a fixed local currency rate based on the contractual amounts in dollars and the local currency, respectively. At maturity, there is also the payment of principal amounts between currencies. The CCIRs are recorded on the Condensed Consolidated Balance Sheets at fair value, with changes in value attributed to the effect of the swaps’ interest spread and changes in the credit worthiness of the counter-parties recorded in Accumulated other comprehensive loss. Changes in value attributed to the effect of foreign currency fluctuations are recorded on the Condensed Consolidated Statements of Operations and offset currency fluctuation effects on the debt principal.
The following table indicates the contractual amounts of the Company's CCIRs at September 30, 2017: | | | | | | | | | | | | | | Interest Rates | (In millions) | | Contractual Amount | | Receive | | Pay | Maturing 2017 | | $ | 0.7 |
| | Floating U.S. dollar rate | | Fixed rupee rate |
The following tables summarize, by major currency, the contractual amounts of the Company’s foreign currency exchange forward contracts in U.S. dollars. The “Buy” amounts represent the U.S. dollar equivalent of commitments to purchase foreign currencies, and the “Sell” amounts represent the U.S. dollar equivalent of commitments to sell foreign currencies. The recognized gains and losses offset amounts recognized in cost of services and products sold principally as a result of intercompany or third party foreign currency exposures. Contracted Amounts of Foreign Currency Exchange Forward Contracts Outstanding at September 30, 2017: | | | | | | | | | | | | | | (In thousands) | | Type | | U.S. Dollar Equivalent | | Maturity | | Recognized Gain (Loss) | British pounds sterling | | Sell | | $ | 70,207 |
| | October 2017 | | $ | (807 | ) | British pounds sterling | | Buy | | 10,638 |
| | October 2017 through January 2018 | | 17 |
| Euros | | Sell | | 317,163 |
| | October 2017 through December 2017 | | (19,028 | ) | Euros | | Buy | | 196,214 |
| | October 2017 through May 2018 | | 792 |
| Other currencies | | Sell | | 50,692 |
| | October 2017 through April 2018 | | (758 | ) | Other currencies | | Buy | | 30,578 |
| | October 2017 through January 2018 | | 239 |
| Total | | | | $ | 675,492 |
| | | | $ | (19,545 | ) |
Contracted Amounts of Foreign Currency Exchange Forward Contracts Outstanding at December 31, 2016: | | | | | | | | | | | | | | (In thousands) | | Type | | U.S. Dollar Equivalent | | Maturity | | Recognized Gain (Loss) | British pounds sterling | | Sell | | $ | 55,120 |
| | January 2017 | | $ | (228 | ) | British pounds sterling | | Buy | | 827 |
| | March 2017 | | (14 | ) | Euros | | Sell | | 326,797 |
| | January 2017 through December 2017 | | 628 |
| Euros | | Buy | | 171,578 |
| | January 2017 through January 2018 | | (468 | ) | Other currencies | | Sell | | 43,455 |
| | January 2017 through September 2017 | | 1,477 |
| Other currencies | | Buy | | 3,106 |
| | March 2017 | | (1 | ) | Total | | | | $ | 600,883 |
| | | | $ | 1,394 |
|
|
Schedule of fair value of financial instruments |
The following table indicates the fair value hierarchy of the financial instruments of the Company: | | | | | | | | | | Level 2 Fair Value Measurements (In thousands) | | September 30 2017 | | December 31 2016 | Assets | | |
| | |
| Foreign currency exchange forward contracts | | $ | 3,245 |
| | $ | 4,932 |
| Interest rate swaps | | 92 |
| | — |
| Cross-currency interest rate swaps | | 110 |
| | 514 |
| Liabilities | | |
| | |
| Foreign currency exchange forward contracts | | 22,790 |
| | 3,538 |
| Interest rate swaps | | 2,970 |
| | — |
|
|
Schedule of the reconciliation of liabilities measured on a recurring basis using unobservable inputs |
The following table reconciles the beginning and ending balances for liabilities measured on a recurring basis using unobservable inputs (Level 3): | | | | | | Level 3 Liabilities—Unit Adjustment Liability (c) for the Nine Months Ended September 30 (In thousands) | | Nine Months Ended | | September 30 | | 2016 | Balance at beginning of period | | $ | 79,934 |
| Reduction in the fair value related to election not to make 2016 payments | | (19,145 | ) | Sale of equity interest in Brand | | (65,461 | ) | Change in fair value to the unit adjustment liability | | 4,672 |
| Balance at end of period | | $ | — |
|
| | (c) | During the quarter ended March 31, 2016, the Company decided that it would not make the four quarterly payments to CD&R for 2016. This resulted in the Company revaluing the Unit Adjustment Liability. The Company sold its investment in Brand in September 2016 and the unit adjustment liability ceased at that time. See Note 4, Equity Method Investment, for additional information related to the unit adjustment liability. |
|